Trials / Unknown
UnknownNCT05880069
Clinical Outcomes in Patients With Infection by Resistant Microorganism
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Hospital Universitario Virgen Macarena · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The goal of this individual patient data meta-analysis is to estimate the attributed and the associated health burden related to bloodstream infections, pneumonia, skin and soft tissue infections, surgical site infections and urinary tract infections, caused by target drug-resistant pathogens, in high income countries. The main question\[s\] it aims to answer are: * Are common infections caused by drug-resistant pathogens associated with an increased health burden, when compared with individuals with the same infection caused by a susceptible strain (attributed burden)? * Are common infections caused by drug-resistant pathogens associated with an increase health burden, when compared with individuals without the infection under study (associated burden)?
Conditions
- Pneumonia
- Bloodstream Infection
- Urinary Tract Infections
- Skin Infection
- Surgical Site Infection
- Staphylococcus Aureus
- Klebsiella Pneumonia
- Escherichia Coli
- Enterococcus Faecium Infection
- Acinetobacter Infections
- Pseudomonas Aeruginosa
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pathogen resistant phenotype | Drug resistant phenotype of the target pathogen under study |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2023-06-01
- Completion
- 2023-10-01
- First posted
- 2023-05-30
- Last updated
- 2023-05-30
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05880069. Inclusion in this directory is not an endorsement.